SCHEMBL6644841

SCHEMBL6644841

Cc1ccc(-c2ccccc2C(=O)Nc2ccc(NCCn3cccn3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
AGTR1 P30556 1/20 0.44
AGTR2 P50052 1/20 0.44
THRB P10828 1/20 0.43
NAMPT P43490 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 2/20 0.43
LMNA P02545 2/20 0.43
RAB9A P51151 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TP53 P04637 2/20 0.43
NFKB1 P19838 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6647425 0.91 SMN1; SMN2 (0.50) ALDH1A1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL7195954 0.88 L3MBTL1 (0.44) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6646034 0.88 APOB (0.48) ALDH1A1NAMPTPOLBGAALMNA
SCHEMBL6644663 0.86 TRPV1 (0.49) ALDH1A1THRBNAMPTNPC1RAB9A
SCHEMBL6644574 0.85 KDR (0.46) ALDH1A1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL6648246 0.84 ALDH1A1 (0.44) ALDH1A1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL6649191 0.82 KMT2A (0.45) ALDH1A1KMT2ACHRNB2CHRNB4CHRNA3
SCHEMBL6644882 0.80 THRB (0.46) ALDH1A1KMT2ATHRBNAMPTPOLB
SCHEMBL6646120 0.80 THRB (0.43) ALDH1A1KMT2ATHRBNAMPTPOLB
SCHEMBL6648345 0.79 THRB (0.41) ALDH1A1KMT2ATHRBNAMPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR ALDH1A1 2174/4885KMT2A 916/4885CHRNB2 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.